0001439222-23-000125.txt : 20230811 0001439222-23-000125.hdr.sgml : 20230811 20230811160451 ACCESSION NUMBER: 0001439222-23-000125 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230809 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foster-Cheek Kaye I CENTRAL INDEX KEY: 0001312622 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 231163968 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20080703 4 1 wk-form4_1691784273.xml FORM 4 X0508 4 2023-08-09 0 0001439222 AGIOS PHARMACEUTICALS, INC. AGIO 0001312622 Foster-Cheek Kaye I C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139 1 0 0 0 0 Common stock 2023-08-09 4 M 0 25000 18.09 A 36524 D Common stock 2023-08-09 4 S 0 25000 25.9555 D 11524 D Common stock 2200 I By Foster Family Revocable Trust Stock options (right to buy) 18.09 2023-08-09 4 M 0 25000 0 D 2032-06-21 Common stock 25000 4307 D The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $25.69 to $26.37. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This option was granted on June 21, 2022. The shares underlying this option vest as to 100% of the underlying shares on June 21, 2023. /s/ William Cook, as Attorney-in-fact for Kaye Foster 2023-08-11